Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC
Cited by 34
Related Papers
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
|Oncogene|2018|111
NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice
|Journal of Molecular Endocrinology|2021|37